Inspection Record

Pine Pharmacy and Home Care Products Center, Inc — FDA 483 Findings

US FDAInspected 2015-07-23Published 2024-01-17 9 findingsAseptic processing and sterility assuranceContamination controlLaboratory and QC controlsEquipment and facilityTraining and personnelStability and storage

Inspectors Karen L. KosarThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Results of stability testing are not used in determining expiration dates Specifically, prescription #REDACTION (b)(6) for Cyclosporin 1% Ophthalmic, sterile veterinary dru g the processing record shows an ingredien t used-Adjuvants Stock for Cyclosporin (a) ey e drop wi th an expiration date of 12/24/13.

2Contamination control

The separate or defined areas necessary to prevent contamination or mix-ups are deficient.

3Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

4Equipment and facility

Equipment and utensils are not sanitized at appropriate intervals to prevent contamination that would alter the safety, identity, strength, quality or purity of the drug product.

5Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established.

6Training and personnel

Employees are not given training in the particular operations they perform as part of their function.

7Stability and storage

An adequate number of batches of each drug product are not tested nor are records ofsuch data maintained to determine a n appropriate expiration date.

8Equipment and facility

Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate des ign to facilit ate operations for its intended u se .

9Training and personnel

Clothing of personnel engaged in the processing of drug products is not appropriate for the duties they perform.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Pine Pharmacy and Home Care Products Center, Inc company profile — full history US FDA documents, 2024 Go to Findings search